NCT06772064View on ClinicalTrials.gov

Efficacy of Rifaximin in Patients With Small Intestinal Bacterial Overgrowth Presenting With Abdominal Bloating.

NARecruitingINTERVENTIONAL

Enrollment

115

Participants

Timeline

Start Date

April 15, 2025

Primary Completion Date

December 1, 2025

Study Completion Date

December 1, 2025

Conditions

SIBO

Interventions

DRUG

Rifaximin (drug)

Rifaximin 0.4g bid for 2 weeks

Trial Locations (1)

250012

RECRUITING

Qilu Hospital of Shandong University, Jinan

All Listed Sponsors

lead

Xiuli Zuo

OTHER